B-intervention	0	17	Multidisciplinary
I-intervention	18	32	rehabilitation
O	33	35	in
O	36	41	women
O	42	51	following
O	52	58	breast
O	59	65	cancer
O	66	75	treatment
O	75	76	:
O	77	78	a
O	79	89	randomized
O	90	100	controlled
O	101	106	trial
O	106	107	.

O	108	110	To
O	111	117	assess
O	118	121	the
O	122	135	effectiveness
O	136	138	of
O	139	140	a
O	141	158	multidisciplinary
O	159	169	ambulatory
O	170	184	rehabilitation
O	185	194	programme
O	195	198	for
O	199	204	women
O	205	214	following
O	215	225	definitive
O	226	232	breast
O	233	239	cancer
O	240	249	treatment
O	250	252	in
O	253	255	an
B-ethinicity	256	266	Australian
O	267	276	community
O	277	283	cohort
O	283	284	.

B-total-participants	285	291	Eighty
I-total-participants	291	292	-
I-total-participants	292	296	five
O	297	302	women
O	303	305	in
O	306	309	the
O	310	319	community
O	320	330	randomized
O	331	333	to
O	334	335	a
O	336	345	treatment
O	346	351	group
O	352	353	(
O	353	354	n
O	355	356	=
B-intervention-participants	357	359	43
O	359	360	)
O	361	364	for
O	365	379	individualized
O	380	384	high
O	384	385	-
O	385	394	intensity
O	395	404	programme
O	404	405	,
O	406	408	or
O	409	410	a
O	411	418	control
O	419	424	group
O	425	426	(
O	426	427	n
O	428	429	=
B-control-participants	430	432	42
O	432	433	)
O	434	444	comprising
B-control	445	450	usual
I-control	451	459	activity
O	459	460	.

O	461	464	The
O	465	472	primary
O	473	480	outcome
B-outcome-Measure	481	491	Depression
I-outcome-Measure	492	499	Anxiety
I-outcome-Measure	500	506	Stress
I-outcome-Measure	507	512	Scale
I-outcome-Measure	513	514	(
I-outcome-Measure	514	518	DASS
I-outcome-Measure	518	519	)
I-outcome-Measure	520	525	scale
O	526	534	measured
O	535	546	restriction
O	547	549	in
O	550	563	participation
O	563	564	.

O	565	574	Secondary
O	575	583	measures
O	584	592	included
B-outcome-Measure	593	602	Perceived
I-outcome-Measure	603	609	Impact
I-outcome-Measure	610	617	Problem
I-outcome-Measure	618	625	Profile
I-outcome-Measure	626	627	(
I-outcome-Measure	627	631	PIPP
I-outcome-Measure	631	632	)
O	633	636	and
B-outcome-Measure	637	643	Cancer
I-outcome-Measure	644	658	Rehabilitation
I-outcome-Measure	659	669	Evaluation
I-outcome-Measure	670	676	System
I-outcome-Measure	677	682	Short
I-outcome-Measure	682	683	-
I-outcome-Measure	683	687	Form
I-outcome-Measure	688	689	(
I-outcome-Measure	689	694	CARES
I-outcome-Measure	694	695	-
I-outcome-Measure	695	697	SF
I-outcome-Measure	697	698	)
O	698	699	;
O	700	703	and
B-outcome-Measure	704	714	Functional
I-outcome-Measure	715	727	Independence
I-outcome-Measure	728	735	Measure
I-outcome-Measure	736	737	(
I-outcome-Measure	737	740	FIM
I-outcome-Measure	740	741	)
I-outcome-Measure	742	747	motor
I-outcome-Measure	748	756	subscale
O	757	760	for
O	761	769	activity
O	770	780	limitation
O	780	781	.

O	782	793	Assessments
O	794	798	were
O	799	801	at
O	802	810	baseline
O	811	814	and
O	815	816	4
O	817	823	months
O	823	824	.

O	825	834	Intention
O	834	835	-
O	835	837	to
O	837	838	-
O	838	843	treat
O	844	852	analysis
O	853	855	of
O	856	860	data
O	861	867	showed
O	868	869	a
O	870	881	significant
O	882	892	difference
O	893	900	between
O	901	905	both
O	906	912	groups
O	913	915	in
B-outcome	916	920	DASS
I-outcome	921	931	Depression
I-outcome	932	938	scores
O	939	940	(
O	940	941	p
O	942	943	=
O	944	945	0
O	945	946	.
O	946	949	006
O	949	950	)
O	951	952	(
O	952	960	moderate
O	961	967	effect
O	968	972	size
O	972	973	,
O	974	975	r
O	976	977	>
O	978	979	0
O	979	980	.
O	980	981	3
O	981	982	)
O	982	983	,
B-outcome	984	988	PIPP
I-outcome	989	997	Mobility
O	998	999	(
O	999	1000	p
O	1001	1002	=
O	1003	1004	0
O	1004	1005	.
O	1005	1007	05
O	1007	1008	)
O	1009	1012	and
B-outcome	1013	1026	Participation
O	1027	1028	(
O	1028	1029	p
O	1030	1031	=
O	1032	1033	0
O	1033	1034	.
O	1034	1036	04
O	1036	1037	)
O	1038	1044	scales
O	1044	1045	,
O	1046	1049	and
B-outcome	1050	1055	CARES
I-outcome	1055	1056	-
I-outcome	1056	1058	SF
I-outcome	1059	1065	Global
I-outcome	1066	1071	score
O	1072	1073	(
O	1073	1074	p
O	1075	1076	=
O	1077	1078	0
O	1078	1079	.
O	1079	1081	02
O	1081	1082	)
O	1083	1084	(
O	1084	1089	small
O	1090	1096	effect
O	1097	1101	size
O	1101	1102	,
O	1103	1104	r
O	1105	1106	<
O	1107	1108	0
O	1108	1109	.
O	1109	1110	3
O	1110	1111	)
O	1111	1112	.

O	1113	1116	The
O	1117	1126	treatment
O	1127	1132	group
O	1132	1133	,
O	1134	1142	compared
O	1143	1147	with
O	1148	1155	control
O	1156	1161	group
O	1161	1162	,
O	1163	1169	showed
O	1170	1181	significant
B-outcome	1182	1193	improvement
I-outcome	1194	1196	in
I-outcome	1197	1200	the
I-outcome	1201	1205	DASS
I-outcome	1206	1216	Depression
I-outcome	1217	1223	scores
O	1223	1224	:
B-iv-bin-abs	1225	1227	22
O	1227	1228	/
B-intervention-participants	1228	1230	42
O	1231	1232	(
B-iv-bin-percent	1232	1234	52
I-iv-bin-percent	1234	1235	.
I-iv-bin-percent	1235	1236	4
I-iv-bin-percent	1236	1237	%
O	1237	1238	)
O	1239	1241	vs
B-cv-bin-abs	1242	1244	12
O	1244	1245	/
B-control-participants	1245	1247	37
O	1248	1249	(
B-cv-bin-percent	1249	1251	32
I-cv-bin-percent	1251	1252	.
I-cv-bin-percent	1252	1253	4
I-cv-bin-percent	1253	1254	%
O	1254	1255	)
O	1256	1257	(
O	1257	1258	p
O	1259	1260	=
O	1261	1262	0
O	1262	1263	.
O	1263	1265	02
O	1265	1266	)
O	1266	1267	.

O	1268	1270	No
O	1271	1281	difference
O	1282	1289	between
O	1290	1296	groups
O	1297	1300	was
O	1301	1306	noted
O	1307	1309	in
O	1310	1313	the
B-outcome	1314	1317	FIM
I-outcome	1318	1323	scale
O	1323	1324	.

O	1325	1339	Rehabilitation
O	1340	1343	can
O	1344	1351	benefit
O	1352	1365	participation
O	1366	1368	in
O	1369	1375	breast
O	1376	1382	cancer
O	1383	1392	survivors
O	1392	1393	.

O	1394	1402	Evidence
O	1403	1406	for
O	1407	1415	specific
O	1416	1430	rehabilitation
O	1431	1444	interventions
O	1445	1447	is
O	1448	1454	needed
O	1454	1455	.

O	1456	1466	Integrated
O	1467	1473	cancer
O	1474	1484	programmes
O	1485	1490	allow
O	1491	1504	opportunities
O	1505	1507	to
O	1508	1516	evaluate
O	1517	1525	patients
O	1526	1528	in
O	1529	1536	various
O	1537	1545	settings
O	1545	1546	,
O	1547	1550	but
O	1551	1558	require
O	1559	1566	outcome
O	1567	1575	research
O	1576	1578	to
O	1579	1586	develop
O	1587	1594	service
O	1595	1601	models
O	1602	1605	for
O	1606	1618	survivorship
O	1619	1625	issues
O	1625	1626	.
